Subscribe to our @JMDiagn newsletter to keep informed about recent editorials, research findings, technical advances and special articles published in The Journal of Molecular Diagnostics. Sign up here: https://t.co/MCb9jVbaUo

ICYMI at #AMPath2025: Researchers at Indiana University Health have created a test that rapidly detects three serious U.S. fungal pathogens: Histoplasma, Blastomyces, and Coccidioides. Read the full release: https://t.co/hS5tTkRUDp

The polls this century and rhetoric this year around congressional redistricting tell us something fundamental, writes @PatMcCroryNC: Trust in the election process rises and falls depending on who wins. "That’s not sustainable in a constitutional republic."

Evaluation of Long-Read Genome Sequencing for Genomic Profiling of Myeloid Cancers. From @AMPath member David Spencer and coauthors from @WashUDeptMed, @washu_pathology and the @GenomeInstitute at @washumedicine. #OpenAccess text: https://t.co/PyID3ZkUNi

Loved reading Laine Morris' reflection on how the AMP annual meeting brings together people committed to advancing personalized medicine. We're looking forward to more of those meaningful exchanges at AMP 2026 in Seattle. Learn about exhibiting: https://t.co/D5M0ezfZsf

Validation and Clinical Utility of a Pan-Cancer Circulating Tumor DNA Assay as a First-Approach Test. From @AMPath member Gang Zheng and colleagues from @MayoClinic. #OpenAccess text: https://t.co/mcSdElNQPE

106lbs of grip strength today up from 104 last week, grip strength and Vo2 max are two of the best predictors of health and longevity we have right now. The flashing of 36.8 is signaling up 36.8 lbs from the last women that I had test their grip strength.

We're now seeking candidates to fill the available leadership positions within our board of directors, committees and subdivisions. Nominate yourself or someone else by Jan. 16! Details: https://t.co/vsWXUES6XA

🚨Don't miss the great opportunity to win FREE registration to #AMP2026 in Seattle! 🧬🧬Consider participating in the social media challenge by @AMPath. The first winner will be announced in March! 🏅🎉#AMPtutorials #SocialMediaChallenge #MolPath @pvhernandezmd @whosainastro

Participate in our #AMPtutorials scicomm contest on social media for a chance to win free registration to #AMP2026 in Seattle next year! How to enter: https://t.co/tiRntfZMd9

ICYMI at #AMPath2025: A Harvard/Brigham and Women’s Hospital team developed a targeted DNA test for X-linked dystonia-parkinsonism, a rare inherited movement disorder primarily affecting men of Filipino descent. Read the full release: https://t.co/ZzwhL7udjA

Attend our FREE webinar at 2:30 p.m. Eastern on Dec. 18 to learn about our new clinical practice guidance and template to improve how complex molecular profiling information is presented to oncologists and other healthcare providers. Register: https://t.co/Bk1vKarfFe

We are now accepting abstracts for #AMPEurope2026 this summer! Submit an abstract to present your work in lovely Tallinn, Estonia. Registration begins Jan. 14. Learn more: https://t.co/eAfZVB8puJ

ICYMI at #AMPath2025: Multiple breakthrough studies in acute myeloid leukemia. 🧬 Genetic mutations after transplant may predict relapse 🧪RNA-based test detects hidden gene fusions 💊 Ultra-sensitive sequencing for residual AML Read the news release: https://t.co/bO1qioPrYj

🧬 If your research enhances the detection, understanding or management of genetic disorders, consider submitting to The Journal of Molecular Diagnostics (@JMDiagn), our official journal. 📖 Explore recent JMD articles on inherited diseases: 👉 https://t.co/f0KOvsSedA

Subscribe to our @JMDiagn newsletter to keep informed about recent editorials, research findings, technical advances and special articles published in The Journal of Molecular Diagnostics. Sign up here: https://t.co/MCb9jVbaUo

Nominate yourself or someone else to fill the available leadership positions within our board of directors, committees and subdivisions by Jan. 16! Details: https://t.co/vsWXUES6XA

ICYMI at #AMPath2025: Researchers at the University of Chicago adapted techniques originally used to study ancient DNA from archaeological specimens to recover genetic information from old medical samples. News release: https://t.co/HpVySHCJ1K

📣 Help recognize achievement and service in the molecular diagnostics community. The 2026 Awards Committee is soliciting outstanding candidates​ for AMP Recognition Awards. ​Self-nominations are encouraged!​ More information here: https://t.co/bNxWLCOHFd

📣 Are you a subject matter expert from a clinical laboratory performing lung cancer biomarker testing? Take our survey on early-stage NSCLC testing by Monday, Dec. 8! Complete the survey here: https://t.co/lhGvy8BrQ1

Clear Labs summed up AMP 2025 this way: Connecting with dedicated clinicians and researchers is what makes the meeting so special. We’re excited to bring that same energy to Seattle for #AMP2026. Join us to learn, share and work together. Exhibitor info: https://t.co/D5M0ezfZsf

Performance Evaluation of the Aptima hrHPV Nucleic Acid Amplification and Papanicolaou Co-Testing in Cervical Cancer Screening: Insights from a Diverse Population-Based Retrospective Study. From @AMPath members at @utmbhealth Full text: https://t.co/k01DhKz219